Fludeoxyglucose F 18 (FLUDEOXYGLUCOSE F-18)
Fludeoxyglucose F 18 (FLUDEOXYGLUCOSE F-18) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Fludeoxyglucose F 18; Generic name: FLUDEOXYGLUCOSE F-18; Drug class: Radioactive Diagnostic Agent [EPC].
| Brand name | Fludeoxyglucose F 18 |
|---|---|
| Generic name | FLUDEOXYGLUCOSE F-18 |
| Drug class | Radioactive Diagnostic Agent [EPC] |
| Manufacturer | Mayo Clinic |
| Used for | 1 INDICATIONS AND USAGE Fludeoxyglucose F 18 Injection USP is indicated for positron emission tomography (PET) imaging in the following settings: Fludeoxyglucose F 18 Injection USP is indicated for positron emission tomography (PET) imaging in the following settings: Oncology: For assessment of abnormal glucose metabolism to assist in the evaluation of malignancy in patients with known or suspected abnormalities found by other testing modalities, or in patients with an existing diagnosis of cancer. Cardiology: For the identification of left ventricular myocardium with residual glucose metabolism and reversible loss of systolic function in patients with coronary artery disease and left ventri |
| Dosage | 2 DOSAGE AND ADMINISTRATION Fludeoxyglucose F 18 Injection USP emits radiation. Use procedures to minimize radiation exposure. Calculate the final dose from the end of synthesis (EOS) time using proper radioactive decay factors. Assay the final dose in a properly calibrated dose calibrator before administration to the patient [ see Description (11.2) ]. Fludeoxyglucose F 18 Injection USP emits radiation. Use procedures to minimize radiation exposure. Screen for blood glucose abnormalities. In th |
| Active ingredient(s) | FLUDEOXYGLUCOSE F-18 |
| Route | INTRAVENOUS |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=153b650d-7b69-4880-a72a-a5f13059d248 |